Oncology PracticeMYSTIC trial analysis IDs mutations prognostic of mNSCLC outcomesSeptember 9, 2019Lung Cancer
Oncology PracticeIASLC survey: Ongoing and intensified molecular testing education needed globallySeptember 8, 2019Lung Cancer
Oncology PracticeNew IASLC declaration targets tobacco use among cancer patientsSeptember 8, 2019Lung Cancer
Oncology PracticeClinical trial enrollment linked to lower death rate in lung cancer patientsSeptember 4, 2019Lung Cancer
Oncology PracticeOut-of-pocket cost of oral TKIs linked to poor lung cancer survivalSeptember 4, 2019Lung CancerPractice Management
Hematology NewsEarly post-ACS bleeding may signal cancerSeptember 1, 2019Bleeding DisordersGI Oncology
Hematology NewsIbrutinib-rituximab induction yields ‘unprecedented’ responses in MCLAugust 27, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsIbrutinib/rituximab effective, safe as frontline treatment for older patients with MCLAugust 12, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsHDAC/HMA combo shows ‘remarkable’ activity in PTCLAugust 9, 2019T Cell LymphomasLymphoma & Plasma Cell Disorders
Oncology PracticeBeyond sunscreen: Skin cancer preventive agents finding a roleAugust 8, 2019Nonmelanoma Skin Cancer
Hematology NewsResearchers combine genetic and clinical factors in new VTE risk scoreJuly 31, 2019ThrombosisLymphoma & Plasma Cell Disorders
Hematology NewsConcizumab looks feasible in hemophilia A and B treatmentJuly 31, 2019Bleeding Disorders
Hematology NewsRNA interference drug fitusiran looks effective in both hemophilia A and BJuly 29, 2019Bleeding Disorders
Hematology NewsEarly phase trial shows durable responses to gene therapy for hemophilia AJuly 29, 2019Bleeding Disorders
